Vertex Pharmaceuticals (VRTX) Deferred Taxes (2011 - 2026)
Vertex Pharmaceuticals (VRTX) posted Deferred Taxes of -$69.7 million for Q2 2026, down 6.74% on a QoQ basis from -$65.3 million in Q1 2026, and up 38.75% year-over-year from -$50.2 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Deferred Taxes (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Deferred Taxes for 16 years, with the latest figure at -$69.7 million in Q2 2026.
- On a quarterly basis, Deferred Taxes rose 38.75% year-over-year to -$69.7 million in Q2 2026; TTM through Jun 2026 was -$340.4 million, a 9.73% increase from a year earlier, with the FY2025 full-year figure at -$510.8 million, down 46.44% from the prior year.
- Deferred Taxes was -$69.7 million for Q2 2026 at Vertex Pharmaceuticals, down from -$65.3 million in the prior quarter.
- The five-year high for Deferred Taxes was $148.1 million in Q4 2022, with the low at -$235.9 million in Q3 2025.
- Average Deferred Taxes over 5 years is -$100.4 million, with a median of -$117.2 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Deferred Taxes surged 453.46% in 2022, then plunged 821.95% in 2023.
- Over 5 years, Deferred Taxes stood at $148.1 million in 2022, then tumbled by 188.45% to -$131.0 million in 2023, then surged by 139.39% to $51.6 million in 2024, then sank by 40.89% to $30.5 million in 2025, then sank by 328.52% to -$69.7 million in 2026.
- The last three Deferred Taxes figures came in at -$69.7 million (Q2 2026), -$65.3 million (Q1 2026), and $30.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -69.70 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | -195.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.70 Mn |
| Mar 31, 2026 | -65.30 Mn |
| Dec 31, 2025 | 30.50 Mn |
| Sep 30, 2025 | -235.90 Mn |
| Jun 30, 2025 | -113.80 Mn |
| Mar 31, 2025 | -191.60 Mn |
| Dec 31, 2024 | 51.60 Mn |
| Sep 30, 2024 | -123.30 Mn |
| Jun 30, 2024 | -118.80 Mn |
| Mar 31, 2024 | -158.30 Mn |
| Dec 31, 2023 | -131.00 Mn |
| Sep 30, 2023 | -115.50 Mn |
| Jun 30, 2023 | -176.60 Mn |
| Mar 31, 2023 | -113.40 Mn |
| Dec 31, 2022 | 148.10 Mn |
| Sep 30, 2022 | -182.30 Mn |
| Jun 30, 2022 | -229.40 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -41.90 Mn |
| Sep 30, 2021 | 68.20 Mn |
API Access
Vertex Pharmaceuticals Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();